๐—™๐—ถ๐—ฟ๐˜€๐˜ ๐——๐—ฎ๐˜† ๐—ฎ๐˜ ๐—–๐—ฃ๐—›๐—œ ๐— ๐—ถ๐—น๐—ฎ๐—ป ๐˜„๐—ถ๐˜๐—ต ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฒ๐˜…๐—ผ๐—ป!

Weโ€™re so excited to be in Milan for CPHI 2024 and meet our friends, partners and clients! This yearโ€™s event is full of amazing opportunities for networking, learning, and sharing insights within our industry.

Our team is eager to connect with industry leaders, participate in engaging discussions, and explore innovative solutions to support our clientsโ€™ development journeys. The atmosphere is vibrant, and we canโ€™t wait to see what exciting experiences await us!

๐—ฆ๐˜๐—ฎ๐˜† ๐˜๐˜‚๐—ป๐—ฒ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜‚๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐˜€ ๐—ฎ๐˜€ ๐˜„๐—ฒ ๐—บ๐—ฎ๐—ธ๐—ฒ ๐—ผ๐˜‚๐—ฟ ๐˜„๐—ฎ๐˜† ๐˜๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐—–๐—ฃ๐—›๐—œ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ!

Latest Posts
Regulatory Intelligence September – October 2024

The Pharmaceutical Industry is incredibly dynamic, with constant updates occurring all through various fields encompassing

๐Ÿšจ Important Update from the European Medicines Agency (EMA) ๐Ÿšจ

This fall a significant EMA update of guideline on Environmental Risk Assessment (ERA) for Medicinal

Pharmexon Company Breakfast

Only a couple of weeks ago, one of Pharmexonโ€™s favorite traditions occurredโ€” the Pharmexon Company

๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฒ๐˜…๐—ผ๐—ป ๐—ต๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฝ๐—น๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด BioBridges Conference ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ฎ๐—ด๐˜‚๐—ฒ!

From September 26th to 27th, the event brought together professionals in bioequivalence and pharmaceutical development,

Pharmexonโ€™s team would like to extend our heartfelt appreciation to all our friends, clients and partners.

CPHI Milan provided an incredible platform for us to meet with both our longstanding friends,